Capital World Investors’s Core Laboratories CLB Stock Holding History

Capital World Investors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-286,000	Closed	-$31.3M	–	526
2017 Q4	$31.3M	Sell	286,000 -530,000	-65%	-$52.9M	0.01%	393
2017 Q3	$80.5M	Sell	816,000 -55,000	-6%	-$5.33M	0.02%	319
2017 Q2	$88.2M	Sell	871,000 -90,198	-9%	-$9.72M	0.02%	293
2017 Q1	$111M	Hold	961,198	–	–	0.03%	279
2016 Q4	$115M	Buy	+961,198	New	+$106M	0.03%	265

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Capital World Investors's CLB Position: Q1 2018 in Review

Capital World Investors sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 286,000 shares — an estimated $31.3M sold.

Capital World Investors first reported a position in CLB in Q4 2016 and held it in 5 quarters. The position peaked at $115M in Q4 2016. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

Capital World Investors reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
Capital World Investors sold 286,000 Core Laboratories shares in Q1 2018, an estimated $31.3M.
Capital World Investors first reported a position in Core Laboratories in Q4 2016 and held it in 5 quarters.
Capital World Investors's Core Laboratories position peaked at $115M in Q4 2016.
355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Capital World Investors's 13F filing for Q1 2018, filed 15 May 2018.